Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Vomiting; fever (acme 38.3 ? c); Acute respiratory insufficiency/respiratory failure; This is a spontaneous report from a contactable physician downloaded from the regulatory authority- IT-MINISAL02-678861. An 83-year-old male patient received the second dose of bnt162b2 (COMIRNATY, Solution for injection, batch/lot number: EL0725, expiration date: 31Mar2021), intramuscular on 04Feb2021 at single dose (1 dose form) in left arm (reported as "left shoulder") for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 04Feb2021, the patient experienced Fever (acme 38.3 Centigrade), Vomiting, Acute respiratory insufficiency. The adverse reaction was severe and the outcome was patient was death. The patient died on 07Feb2021. It was unknown if an autopsy was performed. Reporter comment: Hyperpyrexia and vomiting appeared about 5 hours after the administration of the anti-SARS-Cov2 vaccine. After about 36 hours, respiratory failure with the need for oxygen therapy. The outcome of the events was fatal.; Reporter''s Comments: Hyperpyrexia and vomiting appeared about 5 hours after the administration of the anti-SARS-Cov2 vaccine . After about 36 hours, respiratory failure with the need for oxygen therapy.; Reported Cause(s) of Death: Acute respiratory insufficiency/respiratory failure; Fever (acme 38.3 Centigrade); Vomiting
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166